The spirometer market has seen considerable growth due to a variety of factors.
• The market size for spirometers has seen robust growth in recent years. It's projected to expand from $1.2 billion in 2024 to $1.28 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. This growth during the historic period is linked to a rise in respiratory disease cases, a heightened focus on preventive healthcare, an aging demographic, and an increase in clinical research and practices backed by evidence.
The Spirometer market is expected to maintain its strong growth trajectory in upcoming years.
• The market for spirometers is projected to witness robust expansion in the coming years, with its size anticipated to reach $1.74 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.0%.
The projected growth during this period can be linked to a transition towards home healthcare, ongoing clinical research, effective medical reimbursement policies, and a focus on occupational health monitoring. Noteworthy trends expected to shape the market during this forecast period are remote monitoring and telemedicine, enhanced patient involvement and empowerment, the integration of digital health, the rise of personalized medicine and patient-oriented care, along with market competition and innovation.
The rising occurrence of chronic respiratory disorders is anticipated to fuel the spirometer market's growth. Chronic respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung diseases, are persistent issues affecting the airways and other lung areas. These conditions can be attributed to factors such as smoking, air pollution, workplace exposure, and genetic factors. Spirometers play a crucial role in handling these diseases by assessing lung function, allowing healthcare professionals to track disease progress and the success rate of their treatment. This crucial information helps in modifying drug prescriptions and creating individualized care plans, ultimately improving patients' respiratory wellbeing. For instance, the Australian Institute of Health and Welfare, a government agency, noted in July 2022 that a third (30%) of Australians reported chronic respiratory ailments. Out of an estimated 7.5 million Australians with such conditions, 5.1 million (20% of the overall population) suffered from allergic rhinitis ('hay fever'); 2.7 million (11%) had asthma, and 2.0 million (8.0%) experienced chronic sinusitis (ABS 2022). Thus, the surging prevalence of chronic respiratory ailments is driving the demand for the spirometer market.
The spirometer market covered in this report is segmented –
1) By Type: Hand held, Table Top, Desktop
2) By Technology: Volume Measurement, Flow Measurement, Peak Flow Measurement
3) By Product: Device, Consumables And Accessories, Software
4) By Application: Asthma, COPD, Cystic Fibrous, Pulmonary Fibrosis, Other Applications
5) By End-Use: Hospitals And Clinics, Home Healthcare
Subsegments:
1) By Hand-held: Digital Hand-held Spirometers, Mechanical Hand-held Spirometers
2) By Table Top: Electronic Table Top Spirometers, Ultrasonic Table Top Spirometers
3) By Desktop: Digital Desktop Spirometers, Software-Integrated Desktop Spirometers
Leading businesses in the spirometer industry are concentrating on creating breakthrough solutions such as application-based systems to help individuals monitor their lung health and share these details with healthcare providers. Application-oriented platforms within the spirometer market allow users to assess their lung function, get instantaneous feedback, and provide healthcare experts with data for better management of respiratory disorders. For example, a medical equipment production company based in the US, CMI Health Inc., unveiled AsthmaGo in May 2023. AsthmaGo is a groundbreaking app-driven asthma management platform that combines the SpiroLink digital spirometer, enabling users to efficiently monitor their lung function and oxygen levels at home. This platform enables asthma patients, including children, to effectively control their condition and share health information with caregivers for customized care.
Major companies operating in the spirometer market include:
• Fukuda Sangyo Co. Ltd.
• Geratherm Respiratory GmbH
• Jones Medical Instrument Company
• Koninklijke Philips N.V.
• Ndd Medical Technologies Inc.
• nSpire Health Inc.
• Schiller AG
• Sdi Diagnostics Inc.
• Sibelmed Sau
• Smiths Medical Inc.
• Vitalograph Ltd.
• Vyaire Medical Inc.
• Welch Allyn Inc.
• Baxter International Inc.
• Benson Medical Instruments Co.
• Chest M.I. Inc.
• COSMED srl
• Depisteo LLC
• Henry Schein Inc.
• ICU Medical Inc.
• MGC Diagnostics Corporation
• Midmark Corporation
• Minato Medical Science Co Ltd.
• Nuvoair AB
• OHD (SCHAUENBURG International
• Recorders & Medicare Systems Pvt Ltd.
• Teleflex Incorporated
• Morgan Scientific Inc.
• Futuremed America Inc.
North America was the largest region in the spirometer market share in 2024. The regions covered in the spirometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.